Summary
The aim of this article is to provide an overview of the epidemiology, diagnosis, screening and pharmacotherapy of Chlamydia trachomatis infections in adolescents and adults, together with a critical review of economic studies published on this topic.
C. trachomatis continues to produce enormous social and economic consequences despite advances in prevention, screening and treatment. Both infected men and women are at risk of developing sequelae, although women tend to have more serious complications. Several strategies are available for diagnosis and screening.
In populations with a high prevalence of disease, DNA-amplification assays may be the most cost-effective approach for diagnosis and screening. Empirical treatment of all patients is also cost effective; however, it may not be feasible for all health systems. A single dose of azithromycin is the most cost-effective antimicrobial agent for treatment of C. trachomatis infection.
Article PDF
Similar content being viewed by others
References
Ten leading nationally notifiable infectious diseases: United States, 1995. MMWR Morb Mortal Wkly Rep 1996; 45: 883–4
Recommendations for the prevention and management of Chlamydia trachomatis infections 1993. MMWR Morb Mortal Wkly Rep 1993; 42: 1–39
Gully P, Rwetsiba D. Chlamydial infection in Canada. Can Med Assoc J 1992; 147: 893–6
Crowley T, Horner PJ, Nelki J. Screening associated with reduced infection rates. BMJ 1994; 308: 716–7
Hillis S, Nakashima A, Amsterdam L, et al. Chlamydia trachomatis infections: trends in prevalence, incidence and incidence of recurrent infection, pelvic inflammatory disease and ectopic pregnancy following a comprehensive program. In: Orfila J, Byrne G, Chernesky M, et al., editors. Chlamydial infections. Bologna: Societa Editrice Eescuplapio, 1994: 67–70
Garland S, Gertig D, McInnes J. Genital Chlamydia trachomatis infection in Australia. Med J Aust 1993; 159: 90–6
Patrick DM, Bowie WR. The epidemiology of Chlamydia trachomatis infection in British Columbia. In: Orfila J, Byrne G, Chernesky M, editors. Chlamydial infections. Bologna: Societa Editrice Eescuplapio, 1994: 32–5
Institute of Medicine. The hidden epidemic: confronting sexually transmitted diseases. Washington, DC: National Academy Press, 1996
Saxer J. Chlamydia trachomatis genital infections in a community-based family practice clinic. J Fam Pract 1989; 28: 41–7
Willard MA, Edman RL. Screening for Chlamydia trachomatis in female patients in a primary care setting. J Fam Pract 1989; 28: 97–8
Root D, Hickner J, Nelson T. Prevalence and prediction of chlamydial cervical infection in a rural area: an UPRNet project. J Fam Pract 1991; 33: 369–74
Stergachis A, Scholes D, Heidrich F, et al. Selective screening for Chlamydia trachomatis infection in a primary care population of women. Am J Epidemiol 1993; 138: 143–53
Longhurst LJ, Flower N, Thomas BJ, et al. A simple method for detection of Chlamydia trachomatis infections in general practice. J R Coll Gen Pract 1987; 37: 255–6
Southgate LJ, Treharne J, Williams R. Detection, treatment and follow-up of women with Chlamydia trachomatis infection seeking abortion in inner city general practices. BMJ 1989; 299: 1136–7
Owen PA, Hughes MG, Munro JA. Study of the management of chlamydial cervicitis in general practice. Br J Gen Pract 1991; 41: 279–81
Smith JR, Murdoch J, Carrington D, et al. Prevalence of Chlamydia trachomatis infection in women having cervical smear tests. BMJ 1991; 302: 82–4
Oakeshott P, Chiverston S, Speight J, et al. Testing for cervical Chlamydia trachomatis infection in an inner city practice. Fam Pract 1992; 9: 421–4
Buhaug H, Skjeldestad FE, Halvorsen LE, et al. Should asymptomatic patients be tested for Chlamydia trachomatis in general practice? Br J Gen Pract 1990; 40: 142–5
Avonts D, Sercu M, Heyerick P, et al. Sexually transmitted diseases and Chlamydia trachomatis in women consulting for contraception. J R Coll Gen Pract 1989; 39: 418–20
Bro F, Juul S. Predictors of Chlamydia trachomatis in women in general practice. Fam Pract 1990; 7: 138–43
Brannstrom M, Josefsson G, Cederberg A, et al. Prevalence of genital Chlamydia trachomatis infection among women in a Swedish primary healthcare area. Scand J Infect Dis 1992; 24: 41–6
McNagny SE, Parker RM, Zenilman JM, et al. Urinary leukocyte esterase test: a screening method for the detection of asymptomatic chlamydial and gonococcal infections in men. J Infect Dis 1992; 165: 573–6
Rietmeijer CAM, Judson FN, van Hensbroek MB, et al. Unsuspected Chlamydia trachomatis infection in heterosexual men attending sexually transmitted diseases clinic: evaluation of risk factors and screening methods. Sex Transm Dis 1991; 18: 28–35
Stamm WE, Koutsky LA, Benedetti JK, et al. Chlamydia trachomatis urethral infections in men: prevalence, risk factors and clinical manifestations. Ann Intern Med 1984; 100: 47–51
Shafer M, Prager V, Shalwitz J, et al. Prevalence of urethral Chlamydia trachomatis and Neisseria gonorrhoeae among asymptomatic, sexually active adolescent boys. J Infect Dis 1987; 156: 223–4
Brady M, Baker C, Neinsrein LS. Asymptomatic Chlamydia trachomatis infections in teenage males. J Adolesc Health Care 1988; 9: 72–5
Pelvic inflammatory disease guidelines for prevention and management. MMWR Morb Mortal Wkly Rep 1991; 40: 1–25
Westrom L. Decrease in incidence of women treated in hospital of acute-salpingitis in Sweden. Genitourin Med 1988; 64: 59–63
Kamwendo F, Forslin L, Bodin L, et al. Decreasing incidences of gonorrhea- and chlamydia-associated pelvic inflammatory disease. Sex Transm Dis 1996; 23: 384–91
Pearlman MD, McNeeley G. A review of the microbiology, immunology, and clinical implications of Chlamydia trachomatis infections. Obstet Gynecol Surv 1992; 47: 448–61
Thejls H, Rahm RA, Rosen G, et al. Correlation between chlamydia infection and clinical evaluation, vaginal wet smear and cervical swab tests in female adolescents. Am J Obstet Gynecol 1987; 157: 974–6
Rahm VA, Gnarpe H, Odlind V. Chlamydia trachomatis among sexually active teenage girls: lack of correlation between chlamydia infection, history of patient and clinical signs of infection. Br J Obstet Gynaecol 1988; 95: 916–9
Westrom L, Svensson L, Wolner-Hanssen P, et al. Chlamydial and gonococcal infections in a defined population of women. Scand J Infect Dis 1982; 32 Suppl.: 157–62
Westrom L. Effect of acute pelvic inflammatory disease on fertility. Am J Obstet Gynecol 1975; 121: 707–13
Westrom L, Joesoef R, Reynolds G, et al. Pelvic inflammatory disease and fertility: a cohort study of 1,844 women with laparoscopically verified disease and 657 women with normal laparoscopy. Sex Transm Dis 1992; 19: 185–92
Jones RB, Ardery BR, Hui SL, et al. Correlation between serum antichlamydial antibodies and tubal factor as a cause of infertility. Fertil Steril 1982; 38: 553–8
Weinstock H, Dean D, Bolan G. Chlamydia trachomatis infections. Infect Dis Clin North Am 1994; 8: 797–819
Melekos MD, Asbach HW. The role of chlamydiae in epididymitis. Int J Urol Nephrol 1988; 20: 293–7
Grant JB, Costello CB, Sequeira PJ, et al. The role of Chlamydia trachomatis in epididymitis. Br J Urol 1987; 60: 355–9
Heath CB, Heath JM. Chlamydia trachomatis infection update. Am Fam Physician 1995; 52: 1455–62
Black CM. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev 1997; 10: 160–84
Jones RB, Van Der Pol B, Katz BP. Effect of differences in specimen processing and passage technique on recovery of Chlamydia trachomatis. J Clin Microbiol 1989; 27: 894–8
Mahony JB, Chernesky MA. Effect of swab type and storage temperature on the isolation of Chlamydia trachomatis from clinical specimens. J Clin Microbiol 1985; 22: 865–7
Canadian guidelines for prevention, diagnosis, management and treatment of sexually transmitted diseases in neonates, children, adolescents and adults. Ottawa: Health and Welfare Canada, 1995
Handsfield HH, Alexander ER, Wang SP, et al. Differences in the therapeutic responses of chlamydia positive and chlamydia negative forms of non-gonococcal urethritis. J Am Vener Dis Assoc 1976; 2: 5–9
Bowie WR, Yu JS, Fawcett A, et al. Tetracycline in nongonococcal urethritis: comparison of 2 g and 1 g daily for seven days. Br J Vener Dis 1980; 56: 332–6
Bowie WR, Manzon LM, Borrie-Hume CJ, et al. Efficacy of treatment regimens for lower urogenital Chlamydia trachomatis infections in women. Am J Obstet Gynecol 1982; 142: 125–9
Brunham RC, Kuo C, Stevens CE, et al. Therapy of cervical chlamydial infections. Ann Intern Med 1982; 97: 216–9
Oriel JD, Reeve P, Nicol CS. Minocycline in the treatment of nongonococcal urethritis: its effect on Chlamydia trachomatis. J Am Vener Dis Assoc 1975; 2: 17–22
Oriel JD, Ridgway GL. Comparison of tetracycline and minocycline in the treatment of non-gonococcal urethritis. Br J Vener Dis 1983; 59: 245–8
Ossewaarde JM, Plantema FH, Rieffe M, et al. Efficacy of single dose azithromycin versus doxycycline in the treatment of cervical infections caused by Chlamydia trachomatis. Eur J Clin Microbiol 1992; 11: 693–6
Martin DH, Mroczkowski TF, Dalu ZA, et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. N Engl J Med 1992; 327 (13): 921–5
Nilsen A, Halsos A, Johansen A, et al. A double-blind study of single dose azithromycin and doxycycline in the treatment of chlamydial urethritis in males. Genitourin Med 1992; 68: 325–7
Hammerschlag MR, Golden NH, Oh MK, et al. Single dose of azithromycin for the treatment of genital chlamydial infections in adolescents. J Pediatr 1993; 122: 961–5
Whatley JD, Thin RN, Mumtaz G, et al. Azithromycin versus doxycycline in the treatment of non-gonococcal urethritis. Int J STD AIDS 1991; 2: 248–51
Steingrimsson O, Olafsson JH, Thorarinsson H et al. Azithromycin in the treatment of sexually transmitted disease. JAC 1990; 25 Suppl. A: 109–14
Chow AW, Jewesson PJ. Pharmacokinetics and safety of antimicrobial agents during pregnancy. Rev Infect Dis 1985; 7: 287–313
Walsh M, Kappus EW, Quinn TC. In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis. Antimicrob Agents Chemother 1987; 31: 811–2
Linnemann Jr CC, Heaton CL, Ritchey M. Treatment of Chlamydia trachomatis infections: comparison of 1–and 2–g doses of erythromycin daily for seven days. Sex Transm Dis 1987; 14: 102–6
Robson HG, Shah PP, Lalonde RG, et al. Comparison of rosaramicin and erythromycin stearate for treatment of cervical infection with Chlamydia trachomatis. Sex Transm Dis 1983; 10: 130–4
McCormack WM, George H, Donner A, et al. Hepatotoxicity of erythromycin estolate during pregnancy. Antimicrob Agents Chemother 1977; 12: 630–5
Schachter J, Sweet RL, Grossman M, et al. Experience with routine use of erythromycin for chlamydial infections in pregnancy. N Engl J Med 1986; 314: 276–9
Foulds G, Shepard RM, Johnson RB. The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 1990; 25 Suppl. A: 73–82
Jones RB. New treatments for Chlamydia trachomatis. Am J Obstet Gynecol 1991; 164: 1789–93
Hopkins S. Clinical toleration and safety of azithromycin. Am J Med 1991; 91 Suppl. 3A: 40–5
Batteiger BE, Jones RB, White A. Efficacy and safety of ofloxacin in the treatment of non-gonococcal sexually transmitted disease. Am J Med 1987; 87 Suppl. 6C: 75S–7S
Faro S, Martens MG, Maccato M, et al. Effectiveness of ofloxacin in the treatment of Chlamydia trachomatis and Neisseria gonorrhoeae cervical infection. Am J Obstet Gynecol 1991; 164: 1380–3
Hooton TM, Batteiger BE, Judson FN, et al. Ofloxacin versus doxycycline for treatment of cervical infection with Chlamydia trachomatis. Antimicrob Agents Chemother 1992; 36: 1144–6
Kitchen VS, Donegan C, Ward H, et al. Comparison of ofloxacin with doxycycline in the treatment of nongonococcal urethritis and cervical chlamydial infection. JAC 1990; 26 Suppl. D: 99–105
Maiti H, Chowdhury FH, Richmond SJ, et al. Ofloxacin in the treatment of uncomplicated gonorrhea and chlamydial genital infection. Clin Ther 1991; 13: 441–7
Mogabgab WJ, Holmes B, Murray M, et al. Randomized comparison of ofloxacin and doxycycline for chlamydia and ureaplasma urethritis and cervicitis. Chemotherapy 1990; 36: 70–6
Weber JT, Johnson RE. New treatments for Chlamydia trachomatis genital infection. Clin Infect Dis 1995; 20: S66–71
Schachter J, Sweet RL, Grossman M, et al. Experience with the routine use of erythromycin for chlamydial infections in pregnancy. N Engl J Med 1986; 314: 276–9
McNeeley Jr. SG, Ryan Jr. GM, Baselski V. Treatment of chlamydial infections of the cervix during pregnancy. Sex Transm Dis 1989; 16: 60–2
Crombleholme J, Schachter J, Grossman M, et al. Amoxicillin therapy for C. trachomatis in pregnancy. Obstet Gynecol 1990; 75: 752–6
Magat AH, Alger LS, Nagey DA, et al. Double-blind, randomized study comparing amoxicillin and erythromycin for the treatment of C. trachomatis in pregnancy. Obstet Gynecol 1993; 81: 745–9
Bowie WR. In vitro activity of clavulanic acid, amoxicillin and ticarcillin against C. trachomatis. Antimicrob Agents Chemother 1986; 29: 713–5
Bachmann LH, Stephens J, Richey CM, et al. Measured versus self-reported compliance with doxycycline therapy for Chlamydia associated syndromes [abstract]. 36th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1996 Sep 15–18; New Orleans: 256
Augenbraun M, Wallace T, Dubouchet L, et al. Compliance with doxycycline therapy in an STD clinic [abstract]. 36th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1996 Sept 15-18; New Orleans: 256
Washington AE, Johnson RE, Sanders Jr LL. Chlamydia trachomatis infections in the United States: what are they costing us? JAMA 1987; 257: 2070–2
Cook DJ, Mulrow CD, Haynes B. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med 1997; 126: 376–80
Barr JT, Schumacher GE. Using decision analysis to conduct pharmacoeconomic studies. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. New York: Lippincott Raven Publishers, 1996: 1197–214
Ripa T. Epidemiologic control of genital Chlamydia trachomatis infections. Scand J Infect Dis 1990; 69: 157–67
Herrmann BF, Johansson AB, Mardh PA. A retrospective study of efforts to diagnose infections by Chlamydia trachomatis in a Swedish county. Sex Transm Dis 1991; 18: 233–7
Britton TF, Delisle S, Fine D. STDs and family planning clinics: a regional program for chlamydia control that works. Am J Gynecol Health 1992; 6: 24–31
Addiss D, Vaughn M, Ludka D, et al. Decreased prevalence of Chlamydia trachomatis infection associated with a selective screening program in family planning clinics in Wisconsin. Sex Transm Dis 1993; 20: 28–34
Trachtenberg AI, Washington AE, Halldorson S. A cost-based decision analysis for Chlamydia screening in California family planning clinics. Obstet Gynecol 1988; 71: 101–8
Marrazzo JM, Celum CL, Hillis SD, et al. Performance and cost-effectiveness analysis of selective screening criteria for Chlamydia infection in women: implications for a national chlamydia control strategy. Sex Trans Dis 1997; 24: 131–41
Nettleman MD, Bell TA. Cost-effectiveness of prenatal testing for Chlamydia trachomatis. Am J Obstet Gynecol 1991; 164: 1289–94
Phillips RS, Aronson MD, Taylor WC, et al. Should tests for Chlamydia trachomatis cervical infection be done during routine gynecologic visits? An analysis of the costs of alternative strategies. Ann Intern Med 1987; 107: 188–94
Randolph AG, Washington AE. Screening for Chlamydia trachomatis in adolescent males: a cost-based decision analysis. Am J Public Health 1990; 80: 545–50
Estany A, Todd M, Vasquez M, et al. Early detection of genital chlamydial infection in women: an economic evaluation. Sex Transm Dis 1989; 16: 21–7
Nettleman MD, Jones RB. Cost-effectiveness of screening women at moderate risk for genital infections caused by Chlamydia trachomatis. JAMA 1988; 260: 207–13
Genç M, Mardh PA. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. Ann Intern Med 1996; 124: 1–7
Genç M, Ruusuvaara L, Mardh PA. An economic evaluation of screening for chlamydia trachomatis in adolescent males. JAMA 1993; 270: 2057–64
Patton DL, Askienazy-Elbhar BD, Henry-Suchet J, et al. Detection of Chlamydia trachomatis in Fallopian tube tissue in women with postinfectious tubal infertility. Am J Obstet Gynecol 1994; 171: 95–101
Cates W, Joesoef MR, Goldman MB. Atypical pelvic inflammatory disease: can we identify the clinical predictors? Am J Obstet Gynecol 1993; 169: 341–6
Washington AE, Sweet RL, Schafer M. Pelvic inflammatory disease and its sequelae in adolescents. J Adolesc Health Care 1985; 6: 298–390
Stamm WE, Koutsky LA, Benedetti JK, et al. Chlamydia trachomatis urethral infections in men: prevalence, risk factors, and clinical manisfestations. Ann Intern Med 1984; 100: 47–51
Nettleman MD, Jones RB, Roberts SD, et al. Cost-effectiveness of culturing for Chlamydia trachomatis: a study in a clinic for sexually transmitted diseases. Ann Intern Med 1986; 105: 189–96
Katz BP, Damos S, Quinn TS et al. Efficiency and cost-effectiveness of field follow-up for patients with Chlamydia trachomatis infection in a sexually transmitted diseases clinic. Sex Trans Dis 1988; 15: 11–16
Schiotz HA, Csango PA. Test-of-cure for asymptomatic genital chlamydial infections in women: a cost-benefit analysis. Sex Transm Dis 1992; 19: 133–6
Nuovo J, Melnikow J, Paliescheskey M, et al. Cost-effectiveness analysis of five different antibiotic regimens for the treatment of uncomplicated Chlamydia trachomatis cervicitis. J Am Board Fam Pract 1995; 8: 7–16
Haddix AC, Hillis SD, Kassler WJ. The cost-effectiveness of azithromycin for Chlamydia trachomatis infections in women. Sex Transm Dis 1995; 22: 274–80
Marra F, Marra CA, Patrick D. Cost-effectiveness analysis of azithromycin and doxycycline for Chlamydia trachomatis infection in women: a Canadian perspective. Can J Infect Dis 1997; 8 (4): 202–8
Magid D, Douglas Jr JM, Schwartz JS. Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis. Ann Intern Med 1996: 124: 389–99
Washington AE, Katz P. Cost of and payment source for pelvic inflammatory disease. JAMA 1991; 266: 2565–9
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Marra, C.A., Patrick, D.M., Reynolds, R. et al. Chlamydia trachomatis in Adolescents and Adults. Pharmacoeconomics 13, 191–222 (1998). https://doi.org/10.2165/00019053-199813020-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-199813020-00004